Difference between revisions of "Key molecular pathways in ALS"
From MyWiki
David Hicks (talk | contribs) |
|||
| Line 17: | Line 17: | ||
|- | |- | ||
| VEGF | | VEGF | ||
| + | |||
| + | For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac | ||
|} | |} | ||
Revision as of 07:32, 26 February 2018
| Pathway | Type | Activated by | Inhibited by | Activates | Inhibits |
|---|---|---|---|---|---|
| NF-kappaB | Inflammatory | ||||
| TNF-alpha | |||||
| caspase-3 | |||||
| AMPK-α1 | |||||
| IL-10 | |||||
| SARM1 | |||||
| PKC | |||||
| VEGF
For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac |
